Psychiatric Disorders

Alcohol Use Disorder

American Psychiatric Association. (2018). American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder. https://psychiatryonline.org/doi/pdf/10.1176/appi.books.9781615371969

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Health Disorders. (5th ed.). American Psychiatric Association.

BMJ Best Practice. (2017). Alcohol use disorder. http://bestpractice.bmj.com/topics/en-gb/198

National Council for Behavioral Health. (n.d.) Screening, brief intervention, and referral to treatment. http://www.integration.samhsa.gov/clinical-practice/SBIRT

National Institute on Alcohol Abuse and Alcoholism. (n.d.) Alcohol use disorder. https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/alcohol-use-disorders

Stahl, S. M. (2017). Prescribers guide: Stahl’s Essential Psychopharmacology. (6th ed.). Cambridge University Press.

Windlow, B. T., Onysko, M., Hebert, M. (2016). Medications for alcohol use disorder. American Family Physician, 93(6), 457-465. https://www.aafp.org/afp/2016/0315/p457.html

Anxiety Disorders

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Association.

Anxiety and Depression Society of America. (2015). Clinical practice review for GAD. https://adaa.org/resources-professionals/practice-guidelines-gad#

Bhatt, N.V. (2019). Anxiety disorders treatment & management. Medscape. https://emedicine.medscape.com/article/286227-treatment

BMJ. (2020). Generalized Anxiety Disorder. BMJ Best Practice. http://bestpractice.bmj.com/topics/en-us/120

Gray, S., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R., Crane, P. & Larson, E. (2016). Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ, 352. doi: 10.1136/bmj.i90

McClure, F., Niles, J., Kaufman, H. & Gudin, J. (2017). Concurrent use of opioids and benzodiazepines: Evaluation of prescription drug monitoring by a United States laboratory. Journal of Addiction Medicine, 11(6), 420-426. DOI: 10.1097/ADM.0000000000000354

Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder

American Academy of Pediatrics. (2011). Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 128(5):1007-1022, SI1-SI21.

American Academy of Pediatrics. (2011). Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128:1007.

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). American Psychiatric Association.

American Psychiatric Association (2013). Attention-deficit/hyperactivity disorder. In: Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Centers for Disease Control and Prevention. Data & Statistics. (2014). http://www.cdc.gov/ncbddd/adhd/data.html

Daughton, J. M., Kratochvil, C. J. (2009). Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 240.

Fuller-Thompson, E., Rukshan, M., and Valeo, A. (2014). Establishing a Link Between Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder and Childhood Physical Abuse. Journal of Aggression, Maltreatment & Trauma, 23 (2) http://dx.doi.org/10.1080/10926771.2014.873510

Pliszka, S.; AACAP Work Group on Quality Issues. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 894-921.

Pliszka, S. R., McCracken, J. T., Maas, J. W. (1996). Catecholamines in attention-deficit hyperactivity disorder: current perspectives. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 264.

Rietveld, M. J. Hudziak J. J. Bartels M. et al. (2004). Heritability of attention problems in children: Longitudinal results from a study of twins, age 3 to 12. Journal of Child Psychology Psychiatry, 45, 577-588.

Russell, G., Ford, T., Rosenberg, R. and Kelly, S. (2014). The association of attention deficit hyperactivity disorder with socioeconomic disadvantage, alternative explanation and evidence. Journal of Child Psychology and Psychiatry, 55(5), 436-445.

Sadock, B. & Sadock, V. (2009). Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. (9th ed). Lippincott Williams and Wilkins.

Stahl, S. (2013). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. (4th ed.). Cambridge University Press.

Stahl, S. (2014). The Prescriber's Guide: Essential Psychopharmacology Series. (5th ed.). Cambridge University Press.

Autism Spectrum Disorder

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Centers for Disease Control and Prevention. (2019). Autism Spectrum Disorder. Recommendations and Guidelines. https://www.cdc.gov/ncbddd/autism/hcp-recommendations.html

Centers for Disease Control and Prevention. (2019). Data & Statistics on Autism Spectrum Disorder. https://www.cdc.gov/ncbddd/autism/data.html

Christensen, D. L., Braun, K. V. N., Baio, J., Bilder, D., Charles, J., Constantino, J. N., . . . Yeargin-Allsopp, M. (2018). Prevalence and characteristics of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 Sites, United States, 2012. MMWR Surveill Summ, 65(13), 1-23. doi:10.15585/mmwr.ss6513a1

Fein, D., Carter, A., Bryson, S. E., Carver, L. J., Charman, T., Chawarska, K., … Zwaigenbaum, L. (2016). Commentary on USPSTF final statement on universal screening for autism. Journal of Developmental Behavioral Pediatrics, 37(7), 573-578. doi: 10.1097/DBP.0000000000000345

Guthrie, W., Wallis, K., Bennett, A., Brooks, E., Dudley, J., Gerdes, M., . . . Miller, J. S. (2019). Accuracy of autism screening in a large pediatric network. Pediatrics, 144(4), e20183963. doi:10.1542/peds.2018-3963

Hine, J. F., Allin, J., Allman, A., Black, M., Browning, B., Ramsey, B., . . . Allen, W. (2019). Increasing access to autism spectrum disorder diagnostic consultation in rural and underserved communities: streamlined evaluation within primary care. Journal of Developmental Behavioral Pediatrics, 41(1), 16-22. doi:10.1097/DBP.0000000000000727

Hirsch, L. E., & Pringsheim, T. (2016). Aripiprazole for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, (6), CD009043. Doi: 10.1002/14651858.CD009043.pub3

Hyman, S. L., Levy, S. E., Myers, S. M., Council On Children With Disabilities, S. O. D., & Behavioral, P. (2020). Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics, 145(1). doi:10.1542/peds.2019-3447

Janvier, Y. M., Coffield, C. N., Harris, J. F., Mandell, D. S., & Cidav, Z. (2019). The developmental check-in: development and initial testing of an autism screening tool targeting young children from underserved communities. Autism, 23(3), 689-698. doi:10.1177/1362361318770430

Jobski, K., Hofer, J., Hoffmann, F., & Bachmann, C. (2016). Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review. Acta Psychiatr Scand, 135(1), 8-28. doi: 10.1111/acps.12644

Johnson, H. L., Spahis, J. & Lea, D. H. (2016). Genetic considerations in childhood. In Essential Genetic and Genomic Concepts for Nurses in Leadership, Education, Research, and Clinical Specialty Roles. DEStech Publications.

McPheeters, M. L., Weitlauf, A., Vehorn, A., Taylor, C., Sathe, N. A., Krishnaswami, S., Warren, Z. E. (2016). Screening for Autism Spectrum Disorder in Young Children: A Systematic Evidence Review for the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force.

Monteiro, S. A., Dempsey, J., Berry, L. N., Voigt, R. G., & Goin-Kochel, R. P. (2019). Screening and referral practices for autism spectrum disorder in primary pediatric care. Pediatrics, 144(4), e 20183326. doi:10.1542/peds.2018-3326

Sathe, N., Andrews, J. C., McPheeters, M. L., & Warren, Z. E. (2017). Nutritional and dietary interventions for autism spectrum disorder: a systematic review. Pediatrics, 139(6), e20170346. Doi: 10.1542/peds.2017-0346

Sturner, R., Howard, B., Bergmann, P., Morrel, T., Andon, L., Marks, D., Landa, R. (2016). Autism screening with online decision support by primary care pediatricians aided by M-CHAT/F. Pediatrics, 138(3) e20153036. Doi: 10.1542/peds.2015-3036

Yochum, A. (2016). Autism spectrum/pervasive developmental disorder. Primary Care, 43(2), 285-300. Doi: 10.1016/j.pop.2016.01.010

Eating Disorders: Anorexia Nervosa

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Bargiacchi, A., Clarke, J., Paulsen, A. (2019). European Journal of Pediatrics, 178(3), 413-422. doi:10.1007/s00431-018-3295-7

Bernstein, B. (2020). Anorexia nervosa. Medscape. https://emedicine.medscape.com/article/912187-overview

Crow, S. J. (2019). Pharmacologic treatment of eating disorders. Psychiatric Clinics of North America. 42(2), 253-262. doi:10.1016/j.psc.2019.01.007

Harrington, B. C. (2015). Initial evaluation, diagnosis, and treatment of anorexia nervosa and bulimia nervosa. American Family Physician, 91(1), 46-52. https://www.aafp.org/afp/2015/0101/p46.html

Lock, J. (2019). Updates on treatments for adolescent anorexia nervosa. Child and Adolescent Psychiatric Clinics of North America, 28(4), 523. doi: 10.1016/j.chc.2019.05.001

National Eating Disorders Association. (2016). Anorexia nervosa. https://www.nationaleatingdisorders.org/anorexia-nervosa

Phillipou, A., Abel, L. A., Castle D. J., Gurvich, C., et al. (2019). Midbrain dysfunction in anorexia. Psychiatry Research: Neuroimaging, 283, 154-155. DOI: 10.1016/j.pscychresns.2018.11.004

Yager, J., et al. & American Psychiatric Association Work Group on Eating Disorders. (2006). Practice guidelines for the treatment of patients with eating disorders. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/eatingdisorders.pdf

Eating Disorders: Binge Eating Disorder

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Brownley, K. A., Berkman, N. D., Peat, C. M., et al. (2016). Binge-eating disorder in adults: a systematic review and meta-analysis. Annals of Internal Medicine, 165(6):409-420. doi:10.7326/M15-2455

Citrome, L. (2019). Binge eating disorder revisited: what’s new, what’s different, what next. CNS Spectrums, 24, 4-12. Doi: 10.1017/s1092852919001032

Dorflinger, L. M., Ruser, C. B., & Masheb, R. M. (2017). A brief screening measure for binge eating in primary care. Eating Behaviors, 26, 163-166. https://doi.org/10.1016/j.eatbeh.2017.03.009

Kessler, R., Hutson, P., Herman, B., & Potenza, M. (2016). The neurobiological basis of binge-eating disorder. Neuroscience and Biobehavioral Reviews, 63, 223-238. doi:10.1016/j.neubiorev.2016.01.013

Tsappis, M., Freizinger, M., & Forman, S. F. (2016). Binge-eating disorder: emerging treatments for a new diagnosis. Current Opinion in Pediatrics, 28(4), 415-420. doi:10.1097/MOP.0000000000000367

Wilson, G. (2011). Treatment of binge eating disorder. Psychiatric Clinics of North America, 34(4), 773-773. doi:10.1016/j.psc.2011.08.011

Yanovski, S. Z., Marcus, M. D., Wadden, T. A., & Walsh, T. (2015). The questionnaire on eating and weight patterns-5 (QEWP-5): An updated screening instrument for binge eating disorder. International Journal of Eating Disorders, 48(3), 259-261. https://doi.org/10.1002/eat.22372

Eating Disorders: Bulimia Nervosa

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

American Psychological Association. (2018). Treatment for anorexia and bulimia. http://www.apa.org/topics/eating/treatment.aspx

BMJ Publishing Group. (2017). Bulimia nervosa. BMJ Best Practice. http://bestpractice.bmj.com/topics/en-us/441

Crow, S. J. (2019). Pharmacologic treatment of eating disorders. Psychiatric Clinics of North America, 42, 2, 253-262. doi:10.1016/j.psc.2019.01.007

Gorrell, S. (2019). Update on treatments for adolescent bulimia nervosa. Child and Adolescent Psychiatric Clinics of North America, 28(4), 537-547. doi:10.1016/j.chc.2019.05.002

National Eating Disorders Association. (2016). Bulimia nervosa. https://www.nationaleatingdisorders.org/learn/by-eating-disorder/bulimia

Randhawa, G. (2020). Bulimia nervosa. Medscape. https://emedicine.medscape.com/article/286485-overview

Stahl, S. M., & Grady, M. M. (2017). Stahl's Essential Psychopharmacology. (6th ed.). Cambridge University Press.

Intellectual Disability

American Association on Intellectual and Developmental Disabilities. (n.d.). Frequently asked questions on intellectual disability. https://aaidd.org/intellectual-disability/definition/faqs-on-intellectual-disability#.WrGQOJPwbzU

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Guralnick, M. J. (2016). Early intervention for children with intellectual disabilities: an update. Journal of Applied Research on Intellectual Disabilities, 30(2), 211-229. Doi: 10.1111/jar.12233

Ji, N. Y., & Findling, R. L. (2016). Pharmacotherapy for mental health problems in people with intellectual disability. Current Opinions in Psychiatry, 29(2), 103-125. Doi: 10.1097/YCO.0000000000000233

Johnson, H. L., Spahis, J. & Lea, D. H. (2016). Genetic considerations in childhood. In Essential Genetic and Genomic Concepts for Nurses in Leadership, Education, Research, and Clinical Specialty Roles. DEStech Publications.

Maulik, P. K., Mascarenhas, M. N., Mathers, C. D., Dua, T., & Saxena, S. (2011). Prevalence of intellectual disability: a meta-analysis of population-based studies. Research on Developmental Disabilities, 32(2), 419-436. Doi: 10.1016/j.ridd.2010.12.018

Moeschler, J. B., Shevell, M., & Committee on Genetics. (2014). Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics, 134(3), e903-918. Doi: 10.1542/peds.2014-1839

Toth, K., de Lacy, N., & King, B.H. (2016). Intellectual disability. In M. K. Dulcan (Ed.), Dulcan’s Textbook of Child and Adolescent Psychiatry (2nd ed.). American Psychiatric Association.

Zablotsky, B., Black, L. I., Maenner, M. J., Schieve, L. A., Danielson, M. L., Bitsko, R. H., . . . Boyle, C. A. (2019). Prevalence and trends of developmental disabilities among children in the United States: 2009-2017. Pediatrics, 144(4), e20190811. doi:10.1542/peds.2019-0811

Major Depressive Disorder

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders. (2019). Clinical practice guideline for the treatment of depression across three age cohorts. https://www.apa.org/depression-guideline/guideline.pdf

Blackburn, P., Wilkins, H. M. & Wiese, B. (2017). Depression in older adults: Diagnosis and management. British Colombia Medical Journal, 59(3), 171-177.

Boyd, M. A. (2017). Psychiatric Nursing: Contemporary Practice. (6th ed.). Wolters Kluwer.

Gelenberg, A. J., Freeman, M. P., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trevedi, M. H., Van Rhoads, R. S.; American Psychiatric Association Work Group on Major Depressive Disorder. (2010). Practice Guideline for the Treatment of Patients with Major Depressive Disorder. (3rd ed.). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf

Greenlee, K. & Hyde, P. (2014). Suicide and depression in older adults: Greater awareness can prevent tragedy. Generations: Journal of the American Society on Aging, 38(3), 23-26.

Halter, M. (2017). Varcarolis’ Foundations of Psychiatric Mental Health Nursing: A clinical approach. (8th ed.) Saunders Elsevier.

Halverson, J. L. (2019). Depression. Medscape. https://emedicine.medscape.com/article/286759-overview

Rochester, M., Kane, A., Linnebur, S. & Fixen, D. (2018). Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of evidence. Therapeutic Advances in Drug Safety, 9(6), 297-308. doi:10.1177/2042098618772979

Viola, J. & Warzynski, J. (2017). Psychopharmacology: Clinician’s Pocket Guide. Pink Label Designs.

Obsessive-Compulsive Disorder

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

BMJ Publishing Group. Obsessive-compulsive disorder. (2020). BMJ Best Practice. http://bestpractice.bmj.com/topics/en-us/362

Catapano, F., Perris, F., Fabrazo, M., Cioffi, V., Giacco, D., DeSantis, V., & Maj, M. (2010). Obsessive-compulsive disorder with poor insight: A three-year prospective study. Progress in Neuropsychopharmacology and Biological Psychiatry, 34(2), 323-330. http://dx.doi.org/http://dx.doi.org.lrc1.usuhs.edu/10.1016/j.pnpbp.2009.12.007

Cichocki, C. (2013). Pregnancy during psychiatric syndromes. In K. Tusaie & J. Fitzpatrick (Eds.). Advanced Practice Psychiatric Nursing: Integrating psychotherapy, pharmacology and complementary and alternative approaches (pp. 487-523). Springer Publishing Company, LLC.

Grant, J., Mancebok M., Odlaug, B., Eisen. J., & Rasmussen, S. (2013). Longitudinal course of pharmacotherapy in obsessive-compulsive disorder. International Clinical Psychopharmacology, 28(4), 200-205.

Greenberg, W. M. (2018). Obsessive-compulsive disorder. Medscape. https://emedicine.medscape.com/article/1934139-overview#a4

Heavey, E., Peterson, K. (2019). Treating pediatric acute-onset neuropsychiatric syndrome. Nurse Practitioner, 44(3), 44-49.

Hirschtritt, M. E., Bloch, M. H., & Mathews, C. A. (2017). Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA, 317(13), 1358-1367. doi:10.1001/jama.2017.2200

Kahn, Z., & Salvaggio, M. (2018). Group A Streptococcal infections. https://emedicine.medscape.com/article/228936-overview

Koran, L. M., & Simpson, H. B. (2013). Guidelines watch: Practice guideline for the treatment of patients with obsessive-compulsive disorder. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/ocd-watch.pdf

Phoenix, B., & Johnson, K. (2013). Integrative management of anxiety. In K. Tusaie & J. Fitzpatrick (Eds.), Advanced Practice Psychiatric Nursing (pp. 158-181). Springer Publishing.

Puzantian, T., & Carlat, D. (Eds.). (2016). The Carlat Psychiatry Report: Medication Fact Book for Psychiatric Practice. (3rd ed.). Carlat Publishing, LLC.

Rapoport, J., & Shaw, P. (2015). Obsessive compulsive disorder. In A. Thapar, D. Pine, J. Leckman, S. Scott, M. Snowling, & E. Taylor (Eds.). Rutters Child and Adolescent Psychiatry. John Wiley & Sons, Ltd.

Reddy, Y. C., Sundar, A., Narayanaswamy, J., & Math, S. B. (2017). Clinical practice guidelines for obsessive-compulsive disorder. Indian Journal of Psychiatry, 59(5), 74-90. doi:10.4103/0019-5545.196976

Sadock, B., Sadock, V., & Ruiz, P. (Eds.). (2015). Obsessive-compulsive and related disorders. In Synopsis of Psychiatry (11th ed., pp. 418-436). Wolters Kluwer.

Stahl, S. (2013). Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. (4th ed.). Cambridge University Press.

Stahl, S. (2017). Stahl's Essential Psychopharmacology Prescribers Guide. (6th ed.). Cambridge University Press.

Tobin, V. (2017). Obsessive-compulsive disorder in children and adolescents. Journal of Psychosocial Health and Mental Health Nursing, 56(3), 15-18.

Sleep Disorders: Insomnia

American Academy of Sleep Medicine. (2014). International Classification of Sleep Disorders. (3rd ed.). American Academy of Sleep Medicine.

American Psychiatric Association. (2013). Diagnostic & Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Araújo, T., Jarrin, D. C., Leanza, Y., Vallières, A., & Morin, C. M. (2017). Qualitative studies of insomnia: Current state of knowledge in the field. Sleep Medicine Reviews, 31, 58-69. doi: 10.1016/j.smrv.2016.01.003

Avidan, A. Y., & Neubauer, D. N. (2017). Chronic insomnia disorder. Continuum: Lifelong Learning in Neurology, 23(4), 1064-1092. doi: 10.1212/01.CON.0000522244.13784.bf

Courtauld, H., Notebaert, L., Milkins, B., Kyle, S., Clarke, P. (2017). Individuals with clinically significant insomnia symptoms are characterized by a negative sleep-related expectancy bias: Results from a cognitive-experimental assessment. Behaviour Research and Therapy, 95, 71-78. doi. /10.1016/j.bra

Ellis, J. G., Cushing, T., Germain, A. (2015). Treating acute insomnia: a randomized controlled trial of a “single-shot” of cognitive behavioral therapy for insomnia. Sleep, 38(6), 971-978. doi: 10.5665/sleep.4752

Ellis, J. G., Perlis, M. L., Bastien, C. H., Gardani, M., Espie, C. A. (2014). The natural history of insomnia: acute insomnia and first-onset depression. Sleep, 37(1), 97-106. doi: 10.5665/sleep.3316

Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Freeman, D. (2019). Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry, 76(1), 21-30. doi: 10.1001/jamapsychiatry.2018.2745

Fernandez-Mendoza, J., Vgontzas, A. N., Kritikou, I., Calhoun, S. L., Liao, D., & Bixler, E. O. (2015). Natural history of excessive daytime sleepiness: role of obesity, weight loss, depression, and sleep propensity. Sleep, 38(3), 351-360. DOI: 10.5665/sleep.4488

Hirshkowitz, M., Dautovich, N., Hillygus, S., Knutson, K., & Whiton, K. (2014). 2014 Sleep Health Index. Sleep Foundation. http://sleepfoundation.org/sleep-health-index

Kaldo, V., Jernel, S., Blom, K., Ljotsson, B., Brodin, M., Jorgensen, MJ., Lindefors, N., (2015). Guided internet cognitive behavioral therapy for insomnia compared to a control treatment: A randomized trial. Behaviour Research and Therapy, 71, 90-100. https://doi.org/10.1016/j.brat.2015.06.001

Kreutzmann, J. C., Havekes, R., Abel, T., & Meerlo, P. (2015). Sleep deprivation and hippocampal vulnerability: changes in neuronal plasticity, neurogenesis and cognitive function. Neuroscience, 309, 173-190. DOI: 10.1016/j.neuroscience.2015.04.053

Luyster, F. S., Choi, J., Yeh, C. H., Imes, C. C., Johansson, A. E., & Chasens, E. R. (2015). Screening and evaluation tools for sleep disorders in older adults. Applied Nursing Research, 28(4), 334-340. doi: 10.1016/j.apnr.2014.12.007

Ong, A. D., Kim, S., Young, S., & Steptoe, A. (2017). Positive affect and sleep: A systematic review. Sleep Medicine Reviews, 35, 21-32. DOI: 10.1016/j.smrv.2016.07.006

Palagini, L., Moretto, U., Novi, M., Masci, I., Caruso, D., Drake, C. L., & Riemann, D. (2018). Lack of resilience is related to stress-related sleep reactivity, hyperarousal, and emotion dysregulation in insomnia disorder. Journal of Clinical Sleep Medicine, 14(05), 759-766. DOI: 10.5664/jcsm.7100

Riemann, D., Nissen, C., Palagini, L., Otte, A., Perlis, M. L., & Spiegelhalder, K. (2015). The neurobiology, investigation, and treatment of chronic insomnia. The Lancet Neurology, 14(5), 547-558. DOI: 10.1016/S1474-4422(15)00021-6

Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017). Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 13(02), 307-349. https://doi.org/10.5664/jcsm.6470

Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016). Review of safety and efficacy of sleep medicines in older adults. Clinical Therapeutics, 38(11), 2340-2372. doi: 10.1016/j.clinthera.2016.09.010.

Wickwire, E. M., Shaya, F. T., & Scharf, S. M. (2016). Health economics of insomnia treatments: the return on investment for a good night's sleep. Sleep Medicine Reviews, 30, 72-82. doi: 10.1016/j.smrv.2015.11.004

Winkelman, J.W. (2015). Insomnia disorder. New England Journal of Medicine, 373, 1437-44. doi: 10.1056/NEJMcp141

Wong, M. L., Lau, K. N. T., Espie, C. A., Luik, A. I., Kyle, S. D., & Lau, E. Y. Y. (2017). Psychometric properties of the Sleep Condition Indicator and Insomnia Severity Index in the evaluation of insomnia disorder. Sleep Medicine, 33, 76-81. DOI: 10.1016/j.sleep.2016.05.019

Zion, G. L. (2019). Geriatric sleep disorder. Medscape. http://emedicine.medscape.com/article/292498-overview

Sleep Disorders: Narcolepsy

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Bhattarai, J., Sumerall, S. (2017). Current and future treatment options for narcolepsy: a review. Sleep Science, 10(1), 19-27. doi: 10.5935/1984-0063.20170004

Golden, E. C. & Lipford, M. C. (2018). Narcolepsy: diagnosis and management. Cleveland Clinical Journal of Medicine, 85 (12), 959-969. doi:10.3949/ccjm.85a.17086

Huang, Y., Gilleminault, C., Lin, C., Chen, C., Chin, W., & Chen, T. (2018). Multiple sleep latency test in narcolepsy type 1 and narcolepsy type 2: a 5-year follow-up study. Journal of Sleep Research, 27, 1-9. doi:10.1111/jsr.12700

Karceski, S. (2018). Patient page: About narcolepsy. Neurology, 90 (17), 1544-1547. doi:10.1212/WNL.0000000000005371

Lammers, G. J. (2018). Drugs used in narcolepsy and other hypersomnias. Sleep Medicine Clinics, 13 (2), 183-189. doi.org/10.1016/j.jsmc.2018.02.009

Raggi, A., Plazzi, G. & Ferri, R. (2019). Health-related quality of life in patients with narcolepsy: a review of the literature. The Journal of Nervous and Mental Disease, 207 (2), 84-99 doi: 10.1097/NMD.0000000000000918

Ray, A., Kanabar, K., Upadhyay, V., & Sharma, S. K. (2018). A four-year experience in narcolepsy from a sleep clinic at a tertiary care center with a short review of contemporary Indian literature. The Indian Journal of Medical Research, 148 (6), 748-751. doi:10.4103/ijmr.IJMR_888_16

Romigi, A., Vitrani, G., Lo Giudice, T., Centonze, D., & Franco, V. (2018). Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Design, Development and Therapy, 12, 2665-2675. doi:10.2147/DDDT.S101145

Scammell, T. E. (2015). Narcolepsy. New England Journal of Medicine, 373, 2654-2662. doi:10.1056/NEJMra1500587

Slowik, J. M. (2019). Narcolepsy. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK459236/

Stahl, S. M. (2017). Stahl's Essential Psychopharmacology: Prescriber’s Guide. (6th ed). Cambridge University Press.

Will, K. F., Reaven, N. L., Funk, S. E., McGaughey, K. & Black, J. (2018). Changes in medical services and drug utilization and associated costs after narcolepsy diagnosis in the United States. American Health & Drug Benefits, 11 (3), 137-145. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973250/pdf/ahdb-11-137.pdf

Sleep Disorders: Obstructive Sleep Apnea

American Academy of Sleep Medicine. (2014). International Classification of Sleep Disorders. (3rd ed.). American Academy of Sleep Medicine.

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Aurora, R. N., Collop, N. A., Jacopbowitz, O., Thomas, S. M., Quan, S. F., & Aronsky, A. J. (2015). Quality measures for the care of adult patients with obstructive sleep apnea. Journal of Clinical Sleep Medicine, 11(3), 357-383. DOI: 10.5664/jcsm.4556

Certal, V. F., Zaghi, S., Riaz, M., et al. (2015). Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: a systematic review and meta-analysis. Laryngoscope, 125, 1254. DOI: 10.1002/lary.25032

Epstein, L. J., Kristo, D., Strollo, P. J., Friedman, N., Malhotra, A., Patil, S. P., Weinstein, M. D.; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. (2009). Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med, 5(3), 263-276.

Grover, M., Mookadam, M., Chang, Y. H., Parish, J. (2016). Validating the diagnostic accuracy of the sleep apnea clinical score for use in primary care populations. Mayo Clinic Proceedings, 91, 469. DOI: 10.1016/j.mayocp.2016.01.022

Holcomb, E. M., Schwartz, D. J., McCarthy, M., Thomas, B., Barnett, S. D., & Nakase-Richardson, R. (2016). Incidence, characterization, and predictors of sleep apnea in consecutive brain injury rehabilitation admissions. Journal of Head Trauma Rehabilitation, 31(2), 82-100. DOI: 10.1097/HTR.0000000000000230

Munafo, D. Hevener, W., Crocker, M., Wiles, L., Sridasome, S., & Muhsin, M., (2016). A telehealth program for CPAP adherence reduces labor and yields similar adherence and efficacy when compared to standard of care. Sleep Breath, 20(2), 777-785.

Qaseem, A., Holty, J. C., Owens, D. K., Dallas, P., Starkey, M. & Shekelle, P. (2013). Management of obstructive sleep apnea in adults: a clinical practice guidelines from the American College of Physicians. Annals of Internal Medicine, 159, 471-483. doi: 10.7326/0003-4819-159-7-201310010-00704

Russell, M. B., Kristiansen, H. A., Kværner, K.J. (2014). Headache in sleep apnea syndrome: epidemiology and pathophysiology. Cephalalgia 34:752. doi: 10.1177/0333102414538551.

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Normal sleep and sleep-wake disorders. In: C. Pataki & N. Sussman. Kaplan & Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. (11th ed.). (pp. 550-553). Wolters Kluwer.

Semelka, M., Wilson, J., Flloyd, R. (2016). Diagnosis and treatment of obstructive sleep apnea in adult patients. American Family Physician, 94(5), 355-360. https://www.aafp.org/afp/2016/0901/p355.html

Strollo P. J., Soose, R. J., Maurer, J. T., et al. (2014). Upper-airway stimulation for obstructive sleep apnea. New England Journal of Medicine, 370, 139. DOI: 10.1056/NEJMoa1308659

Trupp, R. J. (2016). Diagnosing sleep apnea in patients hospitalized with heart failure: a role for advanced practice nurses. AACN Advanced Critical Care, 27(1), 15-20. http://dx.doi.org/10.4037/aacnacc2016815

Sleep Disorders: Restless Legs

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Amos, L., Grekowicz, M., Kuhn, E., Olstad, J., Collins, M., Norris, N., & D'Andrea, L. (2014). Treatment of pediatric restless legs syndrome. Clinical Pediatrics, 53(4), 331-336. DOI: 10.1177/0009922813507997

Burbank, F., & Segawa, C. (2018). Medical device alternatives to restless legs syndrome (RLS): dopaminergic drugs. Advances in Neurology and Neuroscience, 1, 7-16.

Calandre, E. P., Rico-Villademoros, F., & Slim, M. (2016). Alpha2 delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics, 16(11), 1263-1277.

International Restless Legs Syndrome Study Group. (2012). 2012 Revised IRLSSG Diagnostic Criteria for RLS. http://irlssg.org/diagnostic-criteria/

Leschziner, G. D. (2018). Restless legs syndrome. In Sleep Disorders in Psychiatric Patients. Springer Publishing.

National Institute of Neurologic Disorders and Stroke. (2017). Restless Legs Syndrome Fact Sheet. NIH Publication No. 17-4847. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Restless-Legs-Syndrome-Fact-Sheet

Picchietti, D. L., Hensley, J. G., Bainbridge, J. L., Lee, K. A., Manconi, M., McGregor, J. A., ... & International Restless Legs Syndrome Study Group. (2015). Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. Sleep Medicine Reviews, 22, 64-77. DOI: 10.1016/j.smrv.2014.10.009

Ulrike, M. H. (2015). Medical devices for restless legs syndrome–clinical utility of the Relaxis pad. Therapeutics & Clinical Risk Management, 1, 1789-1794. DOI: 10.2147/TCRM.S87208

Winkelman, J. W., Armstrong, M. J., Allen, R. P., Chaudhuri, K. R., Ondo, W., Trenkwalder, C., Zee, P. C., Gronseth. G. S., Gloss. D., Zesiewicz, T. (2016). Practice guideline summary: treatment of restless legs syndrome in adults: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology, 87 (24), 2585-2593.

Smoking Cessation

Barua, R. S., Rigotti, N. A., Benowitz, N. L., Cummings, M., Mohammad-Ali, J., Morris, P. B., Rathcford, E. V., Sarna, L., Stecker, E. C., Wiggins, B. S. (2018). 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment. A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. Journal of the American College of Cardiology, 72(25). DOI: 10.1016/j.jacc.2018.10.027. http://www.onlinejacc.org/content/72/25/3332

Brookes, L. (2016). A primer on smoking cessation in primary care. Medscape. https://www.medscape.com/viewarticle/864524

Bruce, S. (2018). Smoking cessation. Clinical Journal of Oncology Nursing, 22(3), 259-261. doi:10.1188/18.CJON.259-261

Centers for Disease Control and Prevention. (2020). Health effects of cigarette smoking. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm

Centers for Disease Control and Prevention (2019) Fact or Fiction: What to Know About Smoking Cessation and Medications. https://www.fda.gov/consumers/consumer-updates/fact-or-fiction-what-know-about-smoking-cessation-and-medications

Gustavson, K., Ystrom, E., Stoltenberg, C., Susser, E., Surén, P., Magnus, P., . . . Reichborn-Kjennerud, T. (2017). Smoking in pregnancy and child ADHD. Pediatrics, 139(2). doi:10.1542/peds.2016-2509

Substance Use Disorder

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Center for Behavioral Health Statistics and Quality. (2020). Key substance use and mental health indicators in the United States. http://www.samhsa.gov/data/

Centers for Disease Control and Prevention. (2020). National Vital Statistics System mortality data. http://www.cdc.gov/nchs/deaths.htm

Coffa, D., & Snyder, H. (2019). Opioid use disorder: medical treatment options. American Family Physician, 100(7), 416-425. https://www.aafp.org/afp/2019/1001/p416.html

Han, B. H., Termined, D. J., Mooree, A. A., Sherman, S. E., & Palamar, J. J. (2018). Medical multimorbidity and drug use among adults in the United States. Preventive Medicine Reports, 12, 214-219. doi: 10.1016/j.pmedr.2018.10.007

Jones, J. L., Mateus, C. F., Malcolm, R. J., Brady, K. T., & Back, S. E. (2018). Efficacy of ketamine in the treatment of substance use disorders: a systematic review. Frontiers in Psychiatry, 9, 277. doi: 10.3389/fpsyt.2018.00277.

Klega, A. E., Tickel Keehbough, J. (2018). Stimulant and designer drug use and primary care management. American Family Physician, 98(2), 85-92. https://www.aafp.org/afp/2018/0715/p85.html

Kulak, J. A. & Griswold, K. S. (2019). Adolescent substance use and misuse: recognition and management. American Family Physician, 99(11), 689-696. https://www.aafp.org/afp/2019/0601/p689.html

Levy, S. J., Williams, J. F., & American Academy of Pediatrics Committee on Substance Use and Prevention. (2016). Substance use screening, brief intervention, and referral to treatment. Pediatrics,138(1): e20161211. DOI: https://doi.org/10.1542/peds.2016-1211

National Council for Behavioral Health. (2018). Implementing care for alcohol & other drug use in medical settings: An extension of SBIRT (SBIRT Change Guide 1.0). https://www.thenationalcouncil.org/wp-content/uploads/2018/03/021518_NCBH_ASPTReport-FINAL.pdf

Olaisen, R. H., Rossen, L. M., Warner, M., & Anderson, R. N. (2019). Unintentional injury death rates in rural and urban areas: United States, 1999-2017. NCHS Data Brief, no 343. https://pubmed.ncbi.nlm.nih.gov/31442193/

Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths-United States, 2013-2017. Morbidity Mortality Weekly Report, 67, 1419–1427. doi: http://dx.doi.org/10.15585/mmwr.mm675152e1

Substance Abuse and Mental Health Services Administration. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf

Substance Abuse and Mental Health Services Administration. (2016). A collaborative approach to the treatment of pregnant women with opioid use disorders. https://ncsacw.samhsa.gov/files/Collaborative_Approach_508.pdf

Substance Abuse and Mental Health Services Administration, Office of the Surgeon General. (2016). Early intervention, treatment, and management of substance use Disorders. In Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. US Department of Health and Human Services. https://www.ncbi.nlm.nih.gov/books/NBK424859/

United States Department of Health and Human Services. (2019). How to respond to opioid overdose. https://www.hhs.gov/opioids/treatment/overdose-response/index.html

U. S. Pharmacist. (2019). Perils of mixing opioids, benzodiazepines. U.S. Pharmacist. https://www.uspharmacist.com/article/perils-of-mixing-opioids-benzodiazepines

Trauma-Related Disorders: Adverse Childhood Events

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Benjet, C., Bromet, E., Karam, E. G., Kessler, R. C., McLaughlin, K. A., Ruscio, A. M., Shahly, V., Stein, D. J., Petukhova, M., … Koenen, K. C. (2016). The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium. Psychological Medicine, 46(2), 327-343. DOI: 10.1017/S0033291715001981

Bright, M. A., Thompson, L. A. (2017). Association of adverse childhood experiences with co-occurring health conditions in early childhood. Journal of Developmental and Behavioral Pediatrics, 39(1), 37-45. doi: 10.1097/DBP.0000000000000514

Centers for Disease Control and Prevention. (2020). About the CDC-Kaiser ACE study. https://www.cdc.gov/violenceprevention/childabuseandneglect/acestudy/about.html

Centers for Disease Control and Prevention. (2019). Adverse childhood experiences. https://www.cdc.gov/vitalsigns/aces/index.html

Everly, G. S. & Lating, J. M. (2017). The John Hopkins Guide to Psychological First Aid. John Hopkins University Press.

Furuta, M., Horsch, A., Ng, E. S. W., Bick, D., Spain, D., & Sin, J. (2018). Effectiveness of trauma-focused psychological therapies for treating post-traumatic stress disorder symptoms in women following childbirth: A systematic review and meta-analysis. Frontiers in Psychiatry, 9, 591. doi: 10.3389/fpsyt.2018.00591

Hawks, L., Woolhandler, S., Himmelstein, D. U., Bor, D. H., Gaffney, A., & McCormick, D. (2019). Association between forced sexual initiation and health outcomes among US women. JAMA Internal Medicine. doi: 10.1001/jamainternalmed.2019.3500

Jones, C. M., Merrick, M. T., Houry, D. E. (2020). Viewpoint: Identifying and preventing adverse childhood experiences. Implications for clinical practice. JAMA, 323(1), 25-26. doi:10.1001/jama.2019.18499

Kalmakis, K. A., & Chandler, G. E. (2015). Health consequences of adverse childhood experiences: A systematic review. Journal of the American Association of Nurse Practitioners, 27(8), 457-465. doi:10.1002/2327-6924.12215

Levy-Carrick, N. C., Lewis-O’Connor, A., Rittenberg, E., Manosalvas, K., Stoklosa, H. M., & Silbersweig, D. A. (2019). Promoting health equity through trauma-informed care. Family and Community Health, 42(2), 104-108.

Lieberman, A. F., Ippen, C. G., & Van Horn, P. (2015). Don’t Hit My Mommy!: A Manual for Child-Parent Psychotherapy with Young Children Exposed to Violence and Other Trauma. (2nd ed.). Zero to Three.

Menschner, C. & Maul, A. (2016). Key ingredients for successful trauma-informed care implementation. Center for Health Care Strategies Brief. https://www.chcs.org/media/Brief-Key-Ingredients-for-TIC-Implementation-1.pdf

Merrick, M. T., Ford, D. C., Ports, K. A., Guinn, A. S., Chen, J., Klevens, J., Metzler, M., Jones, C. M., Simon, T. R., Ottley, P., Mercy, J. A. (2019). Vital Signs: Estimated proportion of adult health problems attributed to adverse childhood experiences and implications for prevention—25 states, 2015-2017. Morbidity and Mortality Weekly Report, 68(44), 999-1005. https://www.cdc.gov/mmwr/volumes/68/wr/mm6844e1.htm?s_cid=mm6844e1_w

Merrick, M. T., Ford, D. C., Ports, K. A. (2018). Prevalence of adverse childhood experiences from the 2011-2014 Behavioral Risk Factor Surveillance System in 23 States. JAMA Pediatrics, 172(11), 1038-1044. doi:10.1001/jamapediatrics.2018.2537

National Child Stress Traumatic Network. (n.d.). Trauma treatments. https://www.nctsn.org/treatments-and-practices/trauma-treatments

Remigio-Baker, R. A., Hayes, D. K., & Reyes-Salvail, F. (2016). The relationship of adverse childhood events to smoking, overweight, obesity and binge drinking among women in Hawaii. Maternal and Child Health Journal, 21(2), 315-325. doi:10.1007/s10995-016-2116-8

Substance Abuse and Mental Health Services Administration. (2014). SAMHSA’s Concept of Trauma and Guidance for a Trauma-Informed Approach. HHS Publication No. (SMA) 14-4884. Substance Abuse and Mental Health Services Administration.

Tomasdottir, M. O., Sigurdsson, J. A., Petursson, H., Kirkengen, A. L., Krokstad, S., McEwen, B., Hetlevik, I. & Getz, L. (2015). Self-reported childhood difficulties, adult multimorbidity and allostatic load. A cross-sectional analysis of the Norwegian HUNT Study. PLoS One, 10(6), e0130591. doi:10.1371/journal.pone.0130591

Trauma-Related Disorders: Domestic Violence

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Arkins, B., Begley, C. & Higgins, A. (2016). Measures for screening for intimate partner violence: a systematic review. Journal of Psychiatric and Mental Health Nursing, 23, 217-235. https://doi.org/10.1111/jpm.12289

Centers for Disease Control & Prevention. (2020). Adverse childhood experiences. https://www.cdc.gov/violenceprevention/childabuseandneglect/acestudy/index.html

Centers for Disease Control & Prevention. (2019). Preventing child abuse and neglect. https://www.cdc.gov/violenceprevention/pdf/CAN-factsheet.pdf

Lizdas, K. C., O’Flaherty, A., Durborow, N., & Marjavi, A. (2019). Compendium of State and U.S. Territory statutes and policies on domestic violence and health care. https://www.futureswithoutviolence.org/wp-content/uploads/Compendium-4th-Edition-2019-Final.pdf

U.S. Department of Health & Human Services, Administration for Children and Families, Administration on Children, Youth and Families, Children’s Bureau. (2020). Child Maltreatment. https://www.acf.hhs.gov/cb/research-data-technology/statistics-research/child-maltreatment

U.S. Preventive Services Task Force. (2018). Clinical Summary: Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: Screening. https://www.uspreventiveservicestaskforce.org/Page/Document/ClinicalSummaryFinal/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening1

World Health Organization. (2017). Violence against women. https://www.who.int/en/news-room/fact-sheets/detail/violence-against-women

World Health Organization. (2020). Elder abuse. https://www.who.int/en/news-room/fact-sheets/detail/elder-abuse

World Health Organization. (2018). WHO recommendation on clinical diagnosis of intimate partner violence in pregnancy. https://extranet.who.int/rhl/topics/preconception-pregnancy-childbirth-and-postpartum-care/antenatal-care/who-recommendation-clinical-diagnosis-intimate-partner-violence-pregnancy

Trauma-Related Disorders: Posttraumatic Stress Disorder

American Academy of Child & Adolescent Psychiatry. (2013). Posttraumatic stress disorder. https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Posttraumatic-Stress-Disorder-PTSD-070.aspx

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Bernardy, N. C., & Friedman, M. J. (2015). Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): What have we learned? Current Psychiatry Reports, 17(4), 1-10. DOI: 10.1007/s11920-015-0564-2

Ehret, M. (2019). Treatment of posttraumatic stress disorder: Focus on pharmacotherapy. The Mental Health Clinician, 9(6), 373-382. doi: 10.9740/mhc.2019.11.373

Kudler, H. (2019). Clinical practice guidelines for posttraumatic stress disorder: Are they still clinical? Psychotherapy, 56(3), 383-390. https://doi.org/10.1037/pst0000236

Lane, R. D., Ryan, L., Nadel, L., Greenberg, L. (2016). Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: new insights from brain science. Behavioral and Brain Science, 38. doi:10.1017/S0140525X14000041

Management of Posttraumatic Stress Disorder Work Group. (2017). Department of Veterans Affairs/Department of Defense clinical practice guideline for the management of post-traumatic stress and acute stress disorder. https://www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGFinal012418.pdf

Morina, N., Lancee, J., Arntz, A. (2017). Imagery rescripting as a clinical intervention for aversive memories: a meta-analysis. Journal of Behavioral and Therapeutic Experimental Psychiatry, 55, 6-15. DOI: 10.1016/j.jbtep.2016.11.003

Prins, A., Bovin, M. J., Kimerling, R., Kaloupek, D. G., Marx, B. P., Pless Kaiser, A., & Schnurr, P. P. (2015). The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5). Journal of General Internal Medicine, 31(10), 1206-1211. doi: 10.1007/s11606-016-3703-5

Smith, P., Dalgleish, T., & Meiser-Stedman, R. (2019). Practitioner review: posttraumatic stress disorder and its treatment in children and adolescents. Journal of Child Psychology and Psychiatry, 60(5), 500-515. doi: 10.1111/jcpp.12983.

Stahl, S. (2018). Prescriber’s Guide Children and Adolescents: Volume 1: Stahl’s Essential Psychopharmacology. Cambridge University Press.

Stahl, S. (2017). Stahl’s Essential Psychopharmacology Prescribers Guide. (6th ed). Cambridge University Press.

Weathers, F. W., Blake, D. D., Schnurr, P. P., Kaloupek, D. G., Marx, B. P., & Keane, T. M. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383-395. doi: 10.1037/pas0000486.

Yücel, D. E. (2020). Comparative efficacy of imagery rehearsal therapy and prazosin in the treatment of trauma-related nightmares in adults: A meta-analysis of randomized controlled trials. Sleep Medicine Reviews, 50, 101248. doi: 10.1016/j.smrv.2019.101248

Zhang, Y. (2020). The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis. Sleep Medicine, 67, 225-231. DOI: 10.1016/j.sleep.2019.06.010

Trauma-Related Disorders: Sexual Assault

Agency for Healthcare Research and Quality. (2016). Trauma-Informed Care. https://www.ahrq.gov/ncepcr/tools/healthier-pregnancy/fact-sheets/trauma.html

Amar, F. A. & Sekula, L .K. (2016). A Practical Guide to Forensic Nursing: Incorporating Forensic Principles into Nursing Practice. Sigma Theta Tau International Publishing.

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders. (5th ed.). American Psychiatric Association.

Centers for Disease Control and Prevention. (2015). Sexually Transmitted Diseases Treatment Guidelines, 2015. MMWR Recommendations and Reports 64 (No. RR-3), 1-137. https://www.cdc.gov/std/treatment/default.htm

Choi, E. S. (2019). The care of the sexual assault patient. Yale Medicine Thesis Digital Library, 3483. https://elischolar.library.yale.edu/ymtdl/3483

U.S. Department of Justice. (2018). National Training Standards for Sexual Assault Medical Forensic Examiners. https://www.justice.gov/ovw/page/file/1090006/download

U.S. Department of Justice. (2016). A National Protocol for Sexual Assault Medical Forensic Examinations: Pediatric. https://www.justice.gov/ovw/file/846856/download

U.S. Department of Justice. (2013). A National Protocol for Sexual Abuse Medical Forensic Examinations: Adults/Adolescents. (2nd ed.). https://www.ncjrs.gov/pdffiles1/ovw/241903.pdf